Johns Hopkins' award-winning legacy
U.S. News & World Report recently named the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center third best in the nation and the top cancer hospital in the Mid-Atlantic Region. The Johns Hopkins Hospital also ranked at the top of its "America's Best Hospitals" Honor roll for the 17th consecutive year.
Elekta Synergy S will be utilized for extracranial radiosurgery, particularly spine and liver applications, says Dr. DeWeese. "The center expects to treat approximately 20 patients per day with Elekta Synergy in the first year," he says, "and about half of those will be stereotactic treatments. Hypofractionated image-guided radiotherapy (IGRT) for prostate applications will follow at a later date as well."
Johns Hopkins also will be using IMPAC for oncology-specific electronic medical records (EMR). IMPAC, an Elekta company, takes oncology management to new levels of efficiency with MOSAIQ(TM), an image-enabled oncology EMR. MOSAIQ supports all aspects of treatment, from patient charting to billing to data and image storage, as well as, patient assessments and access to online clinical images.
Elekta a pioneer in stereotactic radiotherapy and radiosurgery
Elekta Stereotactic Centers of Excellence offer intracranial stereotactic radiosurgery and hypofractionated stereotactic radiosurgery and radiotherapy for applications on all parts of the anatomy. Stereotactic Centers of Excellence are also fully capable of standard radiotherapy treatment, including intensity modulated radiation therapy (IMRT).
Elekta's history of innovation and its advancement of radiotherapy and radiosurgery have made Elekta an industry leader. With the development of Leksell Gamma Knife and the addition of Elekta Synergy S, Elekta provides unprecedented precision and accuracy in stereotactic radiosurgery and stereotactic radiotherapy.
Copyright©2007 PR Newswire.